Abstract
Introduction
Coronary artery disease (CAD), as the most common etiology of heart attack and death in the world, is a multifactorial disease caused by the combined impact of genes [1] . The main etiology of CAD is characterized by defective endothelial function; however, the underlying mechanism has not been fully elucidated despite the high incidence of CAD [2] .. Although there are many recent advancements in treatment, the mortality caused by CAD is still increasing. Genetic features are crucial and constant risk factors for CAD pathogenesis. Recently, one study investigated the relationship between CAD and genetic predisposition and showed that 40% to 60% of the risk for CAD is related to genetic predisposition [3] .
MicroRNAs (miRNAs) are a group of single-stranded, endogenous noncoding RNAs of approximately 22 nucleotides that regulate gene expression via either translational repression or mRNA degradation [4] . MicroRNA-499 (miR-499) is a recently discovered member of the miRNAs encoded by myosin [5] . Under normal physiological circumstances, there is a low expression level of miR-499 regulating the expression of the beta myosin heavy chain, leading to the enhancement of myocardial oxygen metabolism and tolerance [6] . It has recently been demonstrated that miR-499 expression is significantly changed in certain heart diseases such as valvular heart disease, ischemic heart disease and heart failure [7] . MiR-499 has been proven to target genes such as FOXO4 and programmed cell death 4 (PDCD4) [8] .
PDCD4 is a highly conserved RNA-binding protein that inhibits the translation of specific mRNAs [9] . As a significant tumor suppressor, PDCD4 affects translation and transcription of multiple genes, and regulates various signal transduction pathways [10] . It may play a pivotal role in arresting cell cycle progression to inhibit cell proliferation and tumor metastasis [11] . One study showed that it can modulate various signal transduction pathways; specifically, the study results demonstrated that up-regulated miR-182 and down-regulated PDCD4 were observed in ovarian cancer cell lines, while blocking miR-182 in ovarian cancer cell lines resulted in an opposite alteration in endogenous PDCD4 protein expression, which was beneficial for ovarian cancer treatment [10] . Nuclear factor kappa B (NF-κB), one of the most critical signal pathways, regulates genes correlated with proliferation, apoptosis, immune responses, inflammation and tumorigenesis [12] . It can react to harmful stimuli immediately, modulating molecules that involved in the early immunological reaction as well as inflammation in all stages [13] . A study revealed that NF-κB caused apoptosis resistance in cancer and played a role in carcinogenesis [14] . Inflammation is of great significance in cardiovascular disease like atherosclerosis and especially, during the early phase of atherogenesis, inflammation occurs in vascular endothelium and the inflamed endothelial cells can release the pro-inflammatory mediators, including chemokines, pro-inflammatory cytokines, and adhesion molecules [15] . Tumor necrosis factor-alpha (TNF-α) is regarded as a pleiotropic cytokine that is involved in the pathophysiology of inflammatory diseases [16] . CAD, as a chronic inflammatory disease that results from atherosclerosis, is mediated to some extent by proinflammatory cytokines, especially TNF-α, which is often expressed in atherosclerotic plaques [17] . Because the effects of miRNAs have not been systematically explained, we intended to determine the potentially regulatory mechanism of miRNA on certain target genes. Here, we investigated the effects of miR-499 on inflammatory damage in endothelial cells during CAD via the inhibition of the PDCD4 gene through the NF-κB/ TNF-α signaling pathway.
cell morphology observation and imaging. VIII factor-related antigen positive expression in the endothelial cells was detected by immunofluorescence.
Establishment of an inflammatory injury model using endothelial cells
The HUVEC inflammatory injury model was established through the induction of oxidized low-density lipoprotein (OX-LDL) (No. UBC_oxldl, Peking Union-Biology Co. Ltd, Beijing, China) [20] . HUVECs in the logarithmic phase were digested with 0.25% trypsin. A cell suspension was made, and the cell concentration was adjusted to 1 × 10 6 cells/mL; then, 2 mL of DMEM medium containing 100 µg/mL OX-LDL was added. Cells were put in the incubator with 5% CO 2 at 37°C for 24 h. When the cells reached 80%-90% confluence, subculture was performed for subsequent experiments.
Dual-luciferase reporter assay
The miR target gene prediction tool Targetscan (http://www.targetscan.org/vert_71/) was used to predict the binding site of miR-499 in the PDCD43'UTR. The PDCD4 3'UTR promoter region sequence containing the miR-499 binding site was synthesized and inserted at the 5' end BglII site of the pGL3 control vector to construct the PDCD4 3'UTR wild-type (WT) plasmid (named as PDCD4 3'UTR-WT). Using this plasmid, the miR-499 binding site was mutated, and the resultant sequence was used to construct the PDCD4 3'UTR mutant (MUT) plasmid (named as PDCD4 3'UTR-MUT). According to the instructions of the plasmid extraction kit (12145, QIAGEN, Valencia, CA), NC + PDCD4-WT, NC + PDCD4-MUT, miR-499 mimic + PDCD4-WT, miR-499 mimic + PDCD4-MUT, miR-499 inhibitor + PDCD4-WT and miR-499 inhibitor + PDCD4-MUT were transfected into HUVECs. The reporter gene vector used in the experiment was pcDNA3.l-luc, which encodes firefly luciferase. To measure the transfection efficiency, pRL-TK was co-transfected and used as the internal control. The pRL-TK plasmid encoded renilla luciferase. The preheated fluorescent agent was used to set the parameters. After adjusting to zero, 40 μL of LARII and 40 μL of STOP&Glo reagent were added to the sample tube, which was put in the fluorimeter for reading. The fluorescence value was recorded.
Cell grouping and transfection
MiR-499, PDCD4 inhibitor and the analogues that were used in the cell transfection were synthesized by Shanghai GenePharma. Based on the different treatment methods, HUVECs were divided into seven groups: the normal group (normal HUVECs); the OX-LDL group (endothelial cell inflammatory injury model induced by OX-LDL without transfection); the NC group (OX-LDL group with transfection of irrelevant siRNA); the miR-499 inhibitor group (OX-LDL group with transfection of miR-499 inhibitor); the miR-499 mimic group (OX-LDL group with transfection of miR-499 mimic); the PDCD4 siRNA group (OX-LDL group with transfection of PDCD4 inhibitor); and the miR-499 inhibitor + PDCD4 siRNA group (OX-LDL group with transfection of miR-499 inhibitor and PDCD4 inhibitor). Using liposomal Lipofectamine 3000 (CAS: L3000-015, Invitrogen, California, USA), transient transfection was performed. HUVECs were subcultured one day before the transfection. The cells were inoculated into 6-well plates. After cell confluence reached 90 ~ 95%, 50 µL of serum-free medium was used to dilute 1.0 µg of DNA, and then, another 50 µL of serumfree medium was used to dilute 1 µL of Lipofectamine 3000 transfection reagent. After evenly mixing, the solution was mixed with the diluted DNA and put at room temperature for 20 min. After the medium was changed, each well was supplemented with the compound, and the culture plate was shaken to mix the solution evenly. Then, the cells were cultured in the incubator with 5% CO 2 at 37°C. Four hours later, the medium was replaced. After a 48-hour transfection, the subsequent experiment was carried out.
Quantitative real-time polymerase chain reaction (qRT-PCR)
According to the instruction of the kit (CAS: 74104, QIAGEN, Valencia, CA), total RNA of the plasma and cells was extracted. The OD260/280 value of the extracted RNA was detected with an ultraviolet spectrophotometer, and the RNA concentration was calculated. Then, the samples were stored properly at -80°C. Reverse transcription of cDNA was performed following the instructions of the kit (CAS: 205311, QIAGEN, Valencia, CA). Gene sequences published by the GenBank database and the Primer5.0 primer design software were used to design specific primers. The designed primers are displayed in Table 1 . The designed primers were synthesized by Shanghai Sangon Biotech (Shanghai, China). The PCR reaction system was generated in a 20-μL volume: 10 μL of SYBR PremixExTaq, 0. Ct were used to calculate the expression levels of the target genes, and each experiment was repeated three times [21] .
Western blotting
Proteins were extracted from cells in each group, and the concentration was determined in accordance with the instructions of the BCA Kit (No. P0010, Beyotime, Beijing, China). In each well, 30 μg of protein was added and separated by 10% polyacrylamide gel electrophoresis. The electrophoresis voltage was changed from 80 V to 120 V. Wet transfer was carried out, and the transmembrane voltage was 100 mv for 45-70 min. After transferring the proteins to a polyvinylidene fluoride (PVDF) membrane at room temperature, the samples were sealed with 5% bovine serum albumin (BSA) for 1 h. Then, primary anti-mouse monoclonal antibodies against ICAM-1 (CAS: sc-8439, SANTA CRUZ, California, USA), VCAM-1 (CAS:sc-13160, SANTA CRUZ, California, USA), NF-κB p65 (CAS: sc-8008, SANTA CRUZ, California, USA), TNF-α (CAS: sc-133192, SANTA CRUZ, California, USA) and GAPDH (CAS: sc-47724, SANTA CRUZ, California, USA) were added. All of the above antibodies were diluted to 1:1000 and incubated overnight at 4°C. The membrane was washed with tris-buffered saline Tween (TBST) three times for 5 min each. A goat anti-mouse IgG secondary antibody (1: 1000) was incubated with the membrane for 1 h at room temperature. Then, the membrane was washed three times for 5 min each. The Gel Doc EZ imager (Bio-Rad, California, USA) was used to. GAPD visualize the protein bands. GAPDH was used as the internal reference. The Image J software was used to analyze the gray values of the target bands. Each experiment was repeated three times.
Methyl-thiazolyl-tetrazolium (MTT) assay
The diluted cell suspension was inoculated onto a 96-well plate with 5 × 10 4 cells per well. When cells adhered to the wall and the cell confluence reached 80%, the cells were treated as indicated by the experimental grouping. In each group, 6 parallel wells were used. The medium was discarded after 48 h in culture. Serum-free medium was supplemented to every well, and then, the cells were washed 3 times. Then, 20 μL of MTT solution (CAS: M2128-1G, Sigma, CA, USA) was added, and the plates were put in the incubator at 37°C for 4 h; then, the MTT solution was discarded. Then, 150 μL of dimethyl sulfoxide (DMSO) was added into each well. After shaking for 10 min, the optical density (OD) value of each well was recorded at the wavelength of 490 nm in the microplate reader. The experiment was carried out in triplicate, and the 
Enzyme-linked immunosorbent assay (ELISA)
ELISA kits (No. EK0997, Boster, Wuhan, China) were utilized to determine the levels of tumor necrosis factor alpha (TNF-α), interleukin 1 (IL-1), interleukin 6 (IL-6) and interleukin 8 (IL-8). First, the standard solutions, the biotin-labeled antibody and the avidin-biotin-peroxidase complex (ABC) were prepared. Diluted ABC and tetramethylbenzidine (TMB) developing solutions were preheated. The number of ELISA plates was determined. Cell supernatants were taken from each group, and the samples to be detected were acquired following centrifugation; then, 100 μL of the standard samples and the diluted samples were added to the ELISA plate. After reacting with the wells of the plate, the liquid in the plate was discarded. In each well, 100 μL of biotin antibody was added to react for 60 min. The sample was washed three times with PBS, and 100 μL of ABC liquid was added to react for 30 min. Then, the samples were washed five times with PBS, and 90 μL of the TMB developing liquid was added to react without light for 30 min. Finally, 100 μL of TMB stopping buffer was added, and the OD value was measured at a wavelength of 450 nm in the microplate reader. Based on the OD value, the corresponding concentration on the standard curve was found. The final concentration of the sample was detected by multiplying the dilution factor. Each experiment was repeated three times.
Flow cytometry assay
Cell apoptosis was detected using the Annexin V Kit (product No: AP002, Bogoo, Shanghai, China). The medium in each group was collected and placed in the centrifuge tube. The sample was washed with PBS, followed by the addition of 0.25% trypsin for cell digestion. After cell percussion, the digestion liquid was collected and added into the originally collected medium. The samples were centrifuged at 1000 g for 5 min at 4°C, and the cell sediment was collected. The samples were adjusted to achieve a 5 ~ 10 million cell suspension and were centrifuged at 1000 g for 5 min. The supernatant was removed, and 195 μL of Annexin V-FITC binding buffer was added; then, the cells were resuspended. After an addition of 5 μL of Annexin V-FITC, the solution was mixed evenly, incubated for 10 min at room temperature without light and centrifuged at 1000 g for 5 min. The supernatant was removed, and 190 μL of Annexin V-FITC binding buffer was added. Then, 10 μL of propidium iodide (PI) single staining solution was added. After evenly mixing, the sample was restored in an ice bath and prepared for flow cytometry assay (No. FACSCanto II, BD, Jersey, USA). Early apoptosis was set as the lower right quadrant, late apoptosis was set as the upper right quadrant, and the live cells were in the lower left quadrant. The apoptosis rate = the early apoptosis rate + the late apoptosis rate. Each experiment was repeated three times.
Statistical analysis
The SPSS 21.0 statistical software (SPSS, Inc, Chicago, IL, USA) was used. The measurement data are presented as the mean and standard deviation. Comparisons of measurement data with normal distribution between two groups were made using t tests, while comparisons among multiple groups were made using one-way analysis of variance (ANOVA). Correlation analyses were performed using Pearson correlation analysis. P < 0.05 was considered statistically significant.
Results

Relative expression of plasma miR-499 and PDCD4 in the normal and CAD groups
The qRT-PCR was used to detect the mRNA expressions of miR-499 and PDCD4 in the normal and CAD groups. The results showed that compared with the normal group, the expression of miR-499 in the CAD group was significantly increased while that of PDCD4 was significantly decreased (P < 0.05) (Fig. 1A) . The results of the Pearson correlation analysis showed that mRNA expressions of miRNA-499 and PDCD4 were negatively correlated (r = -0.512, P < 0.05) (Fig. 1B) .
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Morphological observation and identification of HUVECs
The morphology of HUVECs was observed under an inverted microscope. It was noted that HUVECs were round, polygonal or spindle shaped. The cells showed monolayer growth without overlapping. A few cells extended and presented in arrangements similar to cobblestones or paving stones after confluence ( Fig. 2A and  B) . VIII factor-related antigen was specific to endothelial cells. The rabbit anti-human VIII factor-related antigen primary antibodies were incubated with a secondary antibody. Green fluorescence was emitted in HUVECs. In the control group, the primary antibody was replaced by PBS, and thus, green fluorescence was not observed (Fig. 2C and D) . The results suggested that the cells isolated from human umbilical vein were endothelial cells.
PDCD4 was verified as the target gene of miR-499
The online miRNA target gene prediction tool Targetscan (http://www.targetscan.org/ vert_71/) predicted the target genes of miR-499. The results showed that the 3'UTR of PDCD4 had 3 potential miR-499 binding sites (Fig. 3A) . Luciferase reporter gene activity assay results showed that in the groups co-transfected with wild-type PDCD4 3'UTR-WT compared with the NC group, the relative activity of luciferase in the miR-499 mimic group was significantly decreased while that in the miR-499 inhibitor group was significantly increased (P < 0.05). A change in luciferase relative activity was not observed following the co-transfection of the NC, miR-499 mimic and miR-499 inhibitor with mutant PDCD4 3'UTR-MUT (P > 0.05) (Fig. 3B) . The results were consistent with the bioinformatics prediction and further confirmed that miR-499 could bind with the 3'-UTR of PDCD4 mRNA, suggesting the targeted inhibition of PDCD4 by miR-499.
Effect of miR-499 targeting PDCD4 on cell proliferation in each group
The MTT assay was performed to measure the cell proliferation rate in each group. The results showed that compared with the normal group, the cell survival rate was significantly 
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Cellular Physiology and Biochemistry decreased in the OX-LDL, NC, miR-499 mimic, PDCD4 siRNA and miR-499 inhibitor + PDCD4 siRNA groups (P < 0.05). Compared to the normal group, there was no significant difference in the miR-499 inhibitor group (P > 0.05). Compared with the OX-LDL and NC groups, the cell survival rate was significantly increased in the miR-499 inhibitor group while those in the miR-499 mimic and PDCD4 siRNA groups were significantly decreased (P < 0.05). There was no significant difference in the miR-499 inhibitor + PDCD4 siRNA group (P > 0.05).
Compared with the PDCD4 siRNA group, the cell survival rate was significantly increased in the miR-499 inhibitor + PDCD4 siRNA group (P < 0.05). No significant differences were noted between the miR-499 mimic and PDCD4 siRNA groups (P > 0.05) (Fig. 5) .
Effect of miR-499 targeting PDCD4 on inflammatory cytokines in each group
ELISA was utilized to detect the levels of IL-6, IL-8, IL-1β and TNF-α in the supernatant. The results showed that compared with the normal group, the levels of IL-6, IL-8, IL-1β and TNF-α were significantly increased in the OX-LDL, NC, miR-499 mimic, PDCD4 siRNA and miR-499 inhibitor + PDCD4 siRNA groups (P < 0.05). Compared with the normal group, there was no significant difference in the miR-499 inhibitor group (P > 0.05). Compared with the OX-LDL and NC groups, the levels of IL-6, IL-8, IL-1β and TNF-α were significantly decreased in the miR-499 inhibitor group while those in the miR-499 mimic and PDCD4 siRNA groups were significantly increased (P < 0.05). There was no significant difference in the miR-499 inhibitor + PDCD4 siRNA group (P > 0.05). Compared with the PDCD4 siRNA group, the levels of IL-6, IL-8, IL-1β and TNF-α were significantly decreased in the miR-499 inhibitor + PDCD4 siRNA group (P < 0.05). There was no significant difference between the miR-499 mimic and PDCD4 siRNA groups (P > 0.05) ( Table 2) . miR-499, microRNA-499; PDCD4, programmed cell death 4; and MTT, methyl-thiazolyl-tetrazolium. Each experiment was repeated three times. Statistically significant differences (P<0.05) were presented using different letters. Table 2 . Comparisons of expressions of inflammatory cytokines in the supernatant in each group (pg/mL), Note: miR-499, microRNA-499; PDCD4, programmed cell death 4; IL-6, Interleukin-6; IL-8, Interleukin-8; IL-1, Interleukin-1; TNF-a, Tumor necrosis factor alpha; NC, negative control; different letters showed significant difference, miR-499, microRNA-499; PDCD4, programmed cell death 4; qRT-PCR, quantitative real-time polymerase chain reaction; P < 0.05, each experiment was repeated for three times, NC, negative control
Effect of miR-499 targeting PDCD4 on cell apoptosis in each group
Flow cytometry was used to detect cell apoptosis. The results showed that compared with the normal group, the cell apoptosis rate was significantly increased in the OX-LDL, NC, miR-499 mimic, PDCD4 siRNA and miR-499 inhibitor + PDCD4 siRNA groups (P < 0.05). Compared with the normal group, there was no significant difference in the miR-499 inhibitor group (P > 0.05). Compared with the OX-LDL and NC groups, the cell apoptosis rate was significantly decreased in the miR-499 inhibitor group while those in the miR-499 mimic and PDCD4 siRNA groups were significantly increased (both P < 0.05). There was no significant difference in the miR-499 inhibitor + PDCD4 siRNA group (P > 0.05). Compared with the PDCD4 siRNA group, the cell apoptosis rate was significantly decreased in the miR-499 inhibitor + PDCD4 siRNA group (P < 0.05). There was no significant difference between the miR-499 mimic and PDCD4 siRNA groups (P > 0.05) (Fig. 6) .
Effect of miR-499 targeting PDCD4 on the NF-κB/TNF-α signaling pathway-related proteins in each group
The qRT-PCR and western blotting were used to determine the mRNA and protein expressions of NF-κB/TNF-α signaling pathway-related proteins (NF-κB, TNF-α, VCAM-1, ICAM-1 and MCP-1) in each group. The results showed that compared with the normal group, the mRNA and protein expressions of NF-κB, TNF-α, VCAM-1, ICAM-1 and MCP-1 were significantly increased in the OX-LDL, NC, miR-499 mimic, PDCD4 siRNA and miR-499 inhibitor + PDCD4 siRNA groups (P < 0.05). Compared with the normal group, there was no significant difference in the miR-499 inhibitor group (P > 0.05). Compared with the OX-LDL Fig. 6 . Comparison of cell apoptosis as detected by flow cytometry in each group. Each experiment was repeated three times. Statistically significant differences (P<0.05) were presented using different letters. Table 3 . Comparisons of mRNA expressions of NF-κB/TNF-α signaling pathway-related proteins detected by qRT-PCR in each group Note: miR-499, microRNA-499; PDCD4, programmed cell death 4; ICAM-1, intercellular cell adhesion molecule-1; MCP-1, monocyte chemotactic protein-1; VCAM-1, vascular cell adhesion molecule-1; NF-κB, nuclear factor-kappa B; TNF-α, tumor necrosis factor-alpha; different letters showed significant difference, P < 0.05; qRT-PCR, quantitative real-time polymerase chain reaction; each experiment was repeated for three times, NC, negative control Cellular Physiology and Biochemistry
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and NC groups, the mRNA and protein expression of NF-κB, TNF-α, VCAM-1, ICAM-1 and MCP-1 was significantly decreased in the miR-499 inhibitor group while those in the miR-499 mimic and PDCD4 siRNA groups were significantly increased (P < 0.05). There was no significant difference in the miR-499 inhibitor + PDCD4 siRNA group (P > 0.05). Compared with the PDCD4 siRNA group, the mRNA and protein expressions of NF-κB, TNF-α, VCAM-1, ICAM-1 and MCP-1 were significantly decreased in the miR-499 inhibitor + PDCD4 siRNA group (P < 0.05). There was no significant difference between the miR-499 mimic and PDCD4 siRNA groups (P > 0.05) ( Table 3 , Fig. 7 ).
Discussion
Currently, CAD incidence is still a main cause of mortality in the world [22] . Endothelial cells are the essential components of various inflammatory diseases, such as psoriasis, diabetes, cancer and rheumatoid arthritis, and chronic inflammation is related to increased atherosclerosis and accelerated cardiovascular mortality and morbidity [23] . Endothelial dysfunction is regarded as one of the significant reason for cardiovascular disease [24] . Increasing evidence has elucidated that mRNAs play a key role in regulating myocardial apoptosis [25, 26] . In our study, we verified the roles of miR-499 and PDCD4 in endothelial cells during CAD.
Our results provided evidence that miR-499 expression was elevated and PDCD4 was down-regulated in the plasma of CAD patients compared to that in the normal group, indicating that miR-499 was negatively correlated with PDCD4. A change in miR-499 expression might be involved in the modulation of the expression of multiple genes and signaling transduction pathways. Recent studies have identified several target genes of miR-499, such as Drp1 and Ets1 [27, 28] . The tumor suppressor PDCD4 is often down-regulated in several malignancies, and its protein expression could be modulated by miR-21, indicating that PDCD4 downregulation is a reliable biomarker for early-stage squamous cell esophageal neoplasia [29] In addition, compared to the normal group, NF-κB and TNF-α expression and the apoptosis rates were all increased. The NF-κB/TNF-α signaling pathway has been reported to promote cancer cell growth, angiogenesis, invasion, and eventually metastasis in many human tumors [30, 31] . As an important transcription factor, NF-κB is responsible for a variety of biological processes that participate in the transcription of proinflammatory genes, thus mediating cellular inflammatory responses, including the elevated expression of chemokines and cytokines [32] . Activation of constitutive NF-kB has been reported to modulate different biological functions, such as cell proliferation, angiogenesis, and inhibition of NF-kB, which protect against atherosclerosis [33] . Silencing of miR-499 could lead to reduced migration and invasion of colorectal cancer (CRC) cells in vitro by modulating PDCD4 [8] . Thus, we concluded that down-regulated miR-499 expression inhibited apoptosis and the secretion of inflammatory factors as well as improved CAD by modulating its functional target, PDCD4, by inhibiting the NF-κB/TNF-α signaling pathways.
In addition, we also found that the levels of IL-6, IL-8 and IL-1β were decreased in the miR-499 inhibitor and miR-499 inhibitor + PDCD4 siRNA groups while elevated in the PDCD4 siRNA group. The endothelial cells can express 59 inflammatory genes, including chemokines, cytokines, chemokine and cytokine receptors, and inflammatory transcription factors, and thus, inflammatory cytokines will be consequently secreted by the inflammatory activation of endothelial cells [34] . As small and active proteins, cytokines regulate cellular growth, function, and differentiation as well as control the immune response and inflammation, including some proinflammatory cytokines such as IL-6 and IL-8 [35] .
Additionally, the results showed that the levels of TNF-α, NF-κB, VCAM-1, ICAM-1 and MCP-1 were reduced in the miR-499 inhibitor and miR-499 inhibitor + PDCD4 siRNA groups while enhanced in the PDCD4 siRNA group. NF-κB is a host of proinflammatory master switch and also inducible transcription factors which are capable of controlling the production of some inflammatory factors [36] . In the vascular endothelium, NF-κB activation induces the expression of proinflammatory genes, including those encoding adhesion molecules, cytokines, and chemoattractant proteins, which collectively contribute to the initiation and development of atherosclerosis [37] . As a proinflammatory, pleiotropic, and homotrimeric soluble cytokine, TNF-α is involved in various metabolic disorders, such as diabetes mellitus [38] and rheumatoid arthritis [39] , and disorders with an inflammatory background, including, but not limited to, atherosclerosis [40] . TNF-α results in the initiation of transcriptional responses via the rapid activation of NF-κB [41] . Chronic inflammation is also a cardinal feature of atherosclerotic vascular disease, in which TNF-α causes endothelial dysfunction that leads to reduced vasodilatory responses [42] . It has been shown that the inhibition of inflammatory pathways may be beneficial for the prevention of vascular damage. TNF-α has also been shown to stimulate endothelial microparticles (EMPs) that are released in endothelial cells and participate in the apoptosis of endothelial cells. Therefore, TNF-α inhibitor have an emerging role in the prevention of vascular dysfunction [43] . A study demonstrated that elevated expression of adhesion cytokines, including VCAM-1 and ICAM-1 in arterial endothelium, might enhance recruitment and adhesion of inflammatory cells, contributing to the progression of plaque instability and atherosclerosis [44] . Elevated levels of ICAM-1 have been found in patients with coronary heart disease, and circulating VCAM-1 levels could be employed to determine the stage of atherosclerosis; additionally, a role for MCP-1 in atherogenesis has also been recently proven [45] . The expressions of VCAM-1, ICAM-1 as well as MCP-1 can be mediated by NF-κB [46] . Thus we can reach a conclusion that down-regulated miR-499 expression protected endothelial cells from inflammatory damage during CAD through the NF-κB/TNF-α signaling pathway. 
Conclusion
Our findings have illustrated that low miR-499 expression contributes to high PDCD4 expression and protects the endothelial cells against inflammatory damage through the NF-κB/TNF-α signaling pathway during CAD. Therefore, miR-499 could be a potential target for the treatment of CAD.
